Home
Scholarly Works
Depemokimab, a Long-Acting (Twice-Yearly)...
Journal article

Depemokimab, a Long-Acting (Twice-Yearly) Monoclonal Antibody for Adults and Adolescents With Severe Eosinophilic Asthma

Authors

Chu AWL; Chu DK

Journal

The Journal of Allergy and Clinical Immunology In Practice, Vol. 13, No. 7, pp. 1868–1870

Publisher

Elsevier

Publication Date

July 1, 2025

DOI

10.1016/j.jaip.2025.03.036

ISSN

2213-2198

Contact the Experts team